TCG Crossover
Venture capital · Palo Alto, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
11Deep-tech portfolio4 active
7Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: BlossomHill Therapeutics
29Co-investorsShare a portfolio company
Portfolio · 11 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| A2 Biotherapeutics | Biotech | Active | Dec 16, 2022 | $118.9M |
| Arbor Biotechnologies | Biotech | Active | Nov 10, 2021 | $227.2M |
| Adcendo | Biotech | Active | — | — |
| Atalanta Therapeutics | Biotech | Active | — | — |
| BlossomHill Therapeutics | Biotech | Public | Dec 10, 2025 | $245.8M |
| RayzeBio | Biotech | Acquired | Sep 22, 2022 | $396.4M |
| Obsidian Therapeutics | Biotech | Public | Dec 8, 2017 | $32.4M |
| Day One Biopharmaceuticals | Biotech | Acquired | — | — |
| Korsana Biosciences | Biotech | Public | — | — |
| Tourmaline Bio | Biotech | Acquired | — | — |
| ViceBio | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#44
Portfolio exits#26
Raises, 12 months#22
Co-investors#62
Co-investors
- Atlas VentureVenture capital2 shared
- Aisling CapitalVenture capital1 shared
- Apple Tree PartnersVenture capital1 shared
- ARCH VentureVenture capital1 shared
- Avoro Capital AdvisorsVenture capital1 shared
- Boxer CapitalVenture capital1 shared
- Brookside CapitalVenture capital1 shared
- Cormorant Asset ManagementVenture capital1 shared
- Foresite CapitalVenture capital1 shared
- F-Prime CapitalVenture capital1 shared
Sectors
- Biotech11
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.